These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 33602971
21. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. Wu YW, Kao HL, Huang CL, Chen MF, Lin LY, Wang YC, Lin YH, Lin HJ, Tzen KY, Yen RF, Chi YC, Huang PJ, Yang WS. Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):399-407. PubMed ID: 22109668 [Abstract] [Full Text] [Related]
22. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. Vucic E, Calcagno C, Dickson SD, Rudd JH, Hayashi K, Bucerius J, Moshier E, Mounessa JS, Roytman M, Moon MJ, Lin J, Ramachandran S, Tanimoto T, Brown K, Kotsuma M, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA. JACC Cardiovasc Imaging; 2012 Aug; 5(8):819-28. PubMed ID: 22897996 [Abstract] [Full Text] [Related]
23. [The value of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) in evaluating the stability of atherosclerotic plaques]. Zhang YH, Tian P, Xu JP, Wang ZZ, Zhao XZ, Nie MX, Zhang MD, Zhao QM, Zhao BT, Song SJ. Zhonghua Nei Ke Za Zhi; 2019 Nov 01; 58(11):808-813. PubMed ID: 31665855 [Abstract] [Full Text] [Related]
24. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Ishii H, Nishio M, Takahashi H, Aoyama T, Tanaka M, Toriyama T, Tamaki T, Yoshikawa D, Hayashi M, Amano T, Matsubara T, Murohara T. Clin Ther; 2010 Dec 01; 32(14):2337-47. PubMed ID: 21353104 [Abstract] [Full Text] [Related]
25. High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. Subramanian S, Emami H, Vucic E, Singh P, Vijayakumar J, Fifer KM, Alon A, Shankar SS, Farkouh M, Rudd JHF, Fayad ZA, Van Dyke TE, Tawakol A. J Am Coll Cardiol; 2013 Dec 24; 62(25):2382-2391. PubMed ID: 24070911 [Abstract] [Full Text] [Related]
26. Arterial wall inflammation in rheumatoid arthritis is reduced by anti-inflammatory treatment. Blanken AB, Agca R, van Sijl AM, Voskuyl AE, Boellaard R, Smulders YM, van der Laken CJ, Nurmohamed MT. Semin Arthritis Rheum; 2021 Apr 24; 51(2):457-463. PubMed ID: 33770536 [Abstract] [Full Text] [Related]
27. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A. J Vis Exp; 2012 May 02; (63):e3777. PubMed ID: 22588186 [Abstract] [Full Text] [Related]
28. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, Farkouh ME, Fayad ZA. Circ Cardiovasc Imaging; 2009 Mar 02; 2(2):107-15. PubMed ID: 19808576 [Abstract] [Full Text] [Related]
29. Should vascular wall 18F-FDG uptake be adjusted for the extent of atherosclerotic burden? Lensen KDF, Voskuyl AE, Comans EFI, van der Laken CJ, Boellaard R, Smulders YM. Int J Cardiovasc Imaging; 2020 Mar 02; 36(3):545-551. PubMed ID: 31898005 [Abstract] [Full Text] [Related]
30. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner. Millon A, Dickson SD, Klink A, Izquierdo-Garcia D, Bini J, Lancelot E, Ballet S, Robert P, Mateo de Castro J, Corot C, Fayad ZA. Atherosclerosis; 2013 Jun 02; 228(2):339-45. PubMed ID: 23582588 [Abstract] [Full Text] [Related]
31. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta. Mizoguchi M, Tahara N, Tahara A, Nitta Y, Kodama N, Oba T, Mawatari K, Yasukawa H, Kaida H, Ishibashi M, Hayabuchi N, Harada H, Ikeda H, Yamagishi S, Imaizumi T. JACC Cardiovasc Imaging; 2011 Oct 02; 4(10):1110-8. PubMed ID: 21999871 [Abstract] [Full Text] [Related]
32. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. Elkhawad M, Rudd JH, Sarov-Blat L, Cai G, Wells R, Davies LC, Collier DJ, Marber MS, Choudhury RP, Fayad ZA, Tawakol A, Gleeson FV, Lepore JJ, Davis B, Willette RN, Wilkinson IB, Sprecher DL, Cheriyan J. JACC Cardiovasc Imaging; 2012 Sep 02; 5(9):911-22. PubMed ID: 22974804 [Abstract] [Full Text] [Related]
33. Effect of Pioglitazone in Combination with Moderate Dose Statin on Atherosclerotic Inflammation: Randomized Controlled Clinical Trial Using Serial FDG-PET/CT. Choo EH, Han EJ, Kim CJ, Kim SH, O JH, Chang K, Seung KB. Korean Circ J; 2018 Jul 02; 48(7):591-601. PubMed ID: 29968431 [Abstract] [Full Text] [Related]
34. Arterial wall inflammation assessed by 18F-FDG-PET/CT is higher in individuals with Type 1 diabetes and associated with circulating inflammatory proteins. Janssen AWM, van Heck JIP, Stienstra R, Aarntzen EHJG, van Diepen JA, Riksen NP, Tack CJ. Cardiovasc Res; 2023 Aug 19; 119(10):1942-1951. PubMed ID: 37079728 [Abstract] [Full Text] [Related]
35. PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers. Hoogeveen RM, Opstal TSJ, Kaiser Y, Stiekema LCA, Kroon J, Knol RJJ, Bax WA, Verberne HJ, Cornel JH, Stroes ESG. JACC Cardiovasc Imaging; 2019 Dec 19; 12(12):2571-2573. PubMed ID: 31422119 [No Abstract] [Full Text] [Related]
36. Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation. Oh M, Lee CW, Lee HS, Chang M, Ahn JM, Park DW, Kang SJ, Lee SW, Kim YH, Moon DH, Park SW, Park SJ. Clin Cardiol; 2016 Nov 19; 39(11):646-652. PubMed ID: 27459273 [Abstract] [Full Text] [Related]
37. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial. Giugliano RP, Keech A, Murphy SA, Huber K, Tokgozoglu SL, Lewis BS, Ferreira J, Pineda AL, Somaratne R, Sever PS, Pedersen TR, Sabatine MS. JAMA Cardiol; 2017 Dec 01; 2(12):1385-1391. PubMed ID: 29117276 [Abstract] [Full Text] [Related]
38. Atherosclerotic plaque metabolism in high cardiovascular risk subjects - A subclinical atherosclerosis imaging study with 18F-NaF PET-CT. Oliveira-Santos M, Castelo-Branco M, Silva R, Gomes A, Chichorro N, Abrunhosa A, Donato P, Pedroso de Lima J, Pego M, Gonçalves L, Ferreira MJ. Atherosclerosis; 2017 May 01; 260():41-46. PubMed ID: 28349887 [Abstract] [Full Text] [Related]
39. Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy. Verhoeven BA, Moll FL, Koekkoek JA, van der Wal AC, de Kleijn DP, de Vries JP, Verheijen JH, Velema E, Busser E, Schoneveld A, Virmani R, Pasterkamp G. Stroke; 2006 Aug 01; 37(8):2054-60. PubMed ID: 16809559 [Abstract] [Full Text] [Related]
40. 18F-Fluorodeoxyglucose-Positron Emission Tomography Imaging Detects Response to Therapeutic Intervention and Plaque Vulnerability in a Murine Model of Advanced Atherosclerotic Disease-Brief Report. Jarr KU, Ye J, Kojima Y, Nanda V, Flores AM, Tsantilas P, Wang Y, Hosseini-Nassab N, Eberhard AV, Lotfi M, Käller M, Smith BR, Maegdefessel L, Leeper NJ. Arterioscler Thromb Vasc Biol; 2020 Dec 01; 40(12):2821-2828. PubMed ID: 33086865 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]